(Q38934525)

English

ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients (English)

1 reference

Europe PubMed Central

7 September 2017

0 references

0 references

Pneumocystis jirovecii

object named as

Pneumocystis jirovecii

1 reference

based on heuristic

inferred from title

Philippe M Hauser

object named as

Philippe M Hauser

7

0 references

object named as

Olga Matos

11

0 references

object named as

Simone Cesaro

2

0 references

Hermann Einsele

4

object named as

Hermann Einsele

1 reference

Europe PubMed Central

7 September 2017

1

object named as

Johan Maertens

1 reference

Europe PubMed Central

7 September 2017

J Peter Donnelly

5

object named as

J Peter Donnelly

1 reference

Europe PubMed Central

7 September 2017

Alexandre Alanio

6

object named as

Alexandre Alanio

1 reference

Europe PubMed Central

7 September 2017

8

object named as

Katrien Lagrou

1 reference

Europe PubMed Central

7 September 2017

Willem Melchers

9

object named as

Willem J G Melchers

1 reference

Europe PubMed Central

7 September 2017

Jannik Helweg-Larsen

10

object named as

Jannik Helweg-Larsen

1 reference

Europe PubMed Central

7 September 2017

Georg Maschmeyer

3

object named as

Georg Maschmeyer

1 reference

Europe PubMed Central

7 September 2017

Stéphane Bretagne

12

object named as

Stéphane Bretagne

1 reference

Europe PubMed Central

7 September 2017

author name string

Catherine Cordonnier

13

1 reference

Europe PubMed Central

7 September 2017

5th European Conference on Infections in Leukaemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organisation for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN)

14

1 reference

Europe PubMed Central

7 September 2017

language of work or name

0 references

publication date

12 May 2016

1 reference

Europe PubMed Central

7 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

7 September 2017

71

1 reference

Europe PubMed Central

7 September 2017

2397-2404

1 reference

Europe PubMed Central

7 September 2017

9

1 reference

Europe PubMed Central

7 September 2017

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Probable mother-to-infant transmission of Pneumocystis carinii f. sp. hominis infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

A systematic review of two different trimetoprim-sulfamethoxazole regimens used to prevent Pneumocystis jirovecii and no prophylaxis at all in transplant recipients: appraising the evidence.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Failure of low-dose atovaquone prophylaxis against Pneumocystis jiroveci infection in transplant recipients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Twice weekly Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Dapsone-induced methemoglobinemia: a dose-related occurrence?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Atovaquone Compared with Dapsone for the Prevention ofPneumocystis cariniiPneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Primary Pneumocystis carinii Prophylaxis with Aerosolized Pentamidine after Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW157

21 January 2018

Identifiers

10.1093/JAC/DKW157

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38934525&oldid=1857505395"